The root causes behind low energy, poor sleep, and stubborn weight gain-and why traditional solutions fail; How GlutLess offers a scripture-based 24-hour wellness system with dist ...

Discover how Primera- formulated by women's health experts Dr. T and Alex Miller-leverages a synergistic blend of plant-based ingredients to naturally support pelvic floor strength, bladder control, ...

Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...

CHENNAI: In a move to strengthen oversight and improve the safety of products reaching American consumers, the US Food and Drug Administration (FDA) has on Tuesday announced that it will increase ...

Health care giantJohnson & Johnson said on Wednesday the US Food and Drug Administration (FDA) has approved its drug to treat patients aged 12 years and older with an immune-mediated disorder.

US FDA Expands Use of Merck's Cancer Drug for Adrenal Gland Tumors (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to ...

The FDA had previously declined to approve the application citing issues at a third-party manufacturing site. The company said last year it had transferred production to an in-house facility.

US FDA Approves AbbVie's Drug for a Type of Lung Cancer (Reuters) -The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

The US Food and Drug Administration (FDA) has approved the first-ever blood test to diagnose the debilitating Alzheimer's disease early. The US Food and Drug Administration (FDA) has approved the ...

This report on the US orphan designated drugs market is the result of comprehensive primary and secondary research, encompassing over 1400 FDA designated orphan drugs, alongside in-depth analysis ...

The vaccine's prospects were thrown into doubt after the FDA missed its April 1 target to approve the shot, which is a more traditional protein-based vaccine unlike its messenger RNA-based rivals. US ...